Physician profile
James T Heywood
NPI 1285612457
$1,186,475.44
in general payments reported to CMS, 2019-2025
45 companies · $118K in 2025
The $118K reported for 2025 was more than what 98% of Advanced Heart Failure and Transplant Cardiology providers received nationally (typical 2025 total: $1,046).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $287K · 2020: $158K · 2021: $131K · 2022: $185K · 2023: $145K · 2024: $162K · 2025: $118K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $223K · Consulting Fee: $143K · Travel and Lodging: $28K · Honoraria: $17K · Food and Beverage: $14K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $222,872.00 |
| Consulting Fee | $143,459.00 |
| Travel and Lodging | $27,664.32 |
| Honoraria | $17,040.00 |
| Food and Beverage | $14,159.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $217,009.23 | 2019-2025 | Clinical Trial Product, Lux-Dx Insertable Cardiac Monitor, Rhythmia Mapping System |
| Actelion Pharmaceuticals US, INC. | $196,709.55 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Abbott Laboratories | $152,766.13 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Mitraclip |
| Boehringer Ingelheim Pharmaceuticals, INC. | $141,612.34 | 2019-2025 | Jardiance |
| Impedimed, INC. | $128,103.37 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $75,792.20 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $71,218.94 | 2022-2025 | Winrevair, Verquvo, Capvaxive |
| Lilly USA, LLC | $43,248.38 | 2019-2025 | Jardiance |
| United Therapeutics Corporation | $41,304.99 | 2019-2025 | Tyvaso, Remodulin, Orenitram |
| Bayer Healthcare Pharmaceuticals INC. | $26,507.92 | 2019-2025 | |
| Biotronik INC. | $15,591.72 | 2019-2023 | Rivacor 7 Dr-T, Acticor 7 Vr-T Dx, Solia |
| Lexicon Pharmaceuticals, INC. | $15,260.85 | 2023-2024 | Inpefa |
| Cvrx, INC. | $11,097.11 | 2022-2025 | Barostim Neo System |
| Medtronic Vascular, INC. | $11,091.60 | 2019-2020 | |
| Scpharmaceuticals INC. | $10,743.75 | 2023-2025 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $6,881.21 | 2019-2025 | Wainua |
| Impulse Dynamics (USA) INC. | $6,411.22 | 2022-2025 | Optimizer |
| Pfizer INC. | $3,733.26 | 2019-2025 | |
| Vifor Pharma, INC. | $3,077.94 | 2019-2021 | |
| Novo Nordisk INC | $2,802.30 | 2021-2025 | Ozempic, Rybelsus |
| Edwards Lifesciences Corporation | $2,606.40 | 2021 | |
| Abiomed | $771.86 | 2019-2025 | Impella |
| Medtronic, INC. | $750.52 | 2021-2025 | Linq II, Micra, Cobalt Dr Mri Surescan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $448.70 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $228.68 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $101.01 | 2019-2022 | |
| Gilead Sciences, INC. | $83.13 | 2019 | |
| Alnylam Pharmaceuticals INC. | $81.45 | 2025 | Amvuttra |
| Otsuka America Pharmaceutical, INC. | $43.83 | 2019 | |
| Cardiac Dimensions, INC. | $41.21 | 2023 | |
| Daiichi Sankyo INC. | $39.35 | 2022-2024 | Injectafer |
| Kiniksa Pharmaceuticals, Ltd. | $38.78 | 2023 | Arcalyst |
| Philips North America LLC | $34.71 | 2023 | |
| Kiniksa Pharmaceuticals International, Plc | $31.90 | 2024 | Arcalyst |
| Celgene Corporation | $31.50 | 2023 | Camzyos |
| Amgen INC. | $31.08 | 2020-2025 | Repatha |
| Baxter Healthcare | $30.10 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor |
| Kestra Medical Technology Services, INC. | $27.92 | 2025 | Assure Wcd |
| Akcea Therapeutics, INC. | $24.89 | 2020 | |
| Sanofi-Aventis U.S. LLC | $21.76 | 2021 | |
| Viiv Healthcare Company | $17.81 | 2024 | Cabenuva |
| Irhythm Technologies, INC. | $17.61 | 2024 | Zio Xt Patch |
| Analog Devices INC. | $7.23 | 2024 | Sensinel Cpm Wearable |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,123.83 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Heywood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.